Cargando…
Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer
Polycomb repressive complex 2 (PRC2), which is responsible for the trimethylation of H3K27 (H3K27me3), plays a part in tumorigenesis, development and/or maintenance of adult tissue specificity. The pivotal role of PRC2 in cancer makes it a therapeutic target for epigenetic cancer therapy. However, n...
Autores principales: | Chen, Huiming, Gao, Shijuan, Li, Jiandong, Liu, Dong, Sheng, Chunjie, Yao, Chen, Jiang, Wei, Wu, Jiaoxiang, Chen, Shuai, Huang, Wenlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536998/ https://www.ncbi.nlm.nih.gov/pubmed/25944687 |
Ejemplares similares
-
Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013) -
Polycomb Repressive
Complex 2 Modulation through the
Development of EZH2–EED Interaction Inhibitors and EED Binders
por: Tomassi, Stefano, et al.
Publicado: (2021) -
PRC2/EED-EZH2 Complex Is Up-Regulated in Breast Cancer Lymph Node Metastasis Compared to Primary Tumor and Correlates with Tumor Proliferation In Situ
por: Yu, Hongxiang, et al.
Publicado: (2012) -
Wedelolactone Promotes the Chondrogenic Differentiation of Mesenchymal Stem Cells by Suppressing EZH2
por: Qin, Wei, et al.
Publicado: (2023) -
The BAF and PRC2 Complex Subunits Dpf2 and Eed Antagonistically Converge on Tbx3 to Control ESC Differentiation
por: Zhang, Wensheng, et al.
Publicado: (2019)